AKT1 and myasthenia gravis: The phosphorylation of AKT was significantly increased in the MG group compared with Control group (p < 0.05), while luteolin pre-treatment (5 and 10 μM) decreased the p-AKT compared with MG group (p < 0.05) (see Supplementary Fig. S3A).